Condition: Respiratory Depression · Sponsor: Enalare Therapeutics Inc.
This study is a Phase I clinical trial to assess the safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles with single intravenous (IV) and intramuscular (IM) doses of ENA-001.
This description comes directly from the study's public registry record.
Mathews · 908-947-5491 · jmathews@enalare.com
Always discuss trial participation with your own doctor first.
| South Florida Research Phase I-IV | Miami, Florida, United States | Recruiting |
| Dr. Vince Clinical Research | Overland Park, Kansas, United States | Completed |
| Clinilabs | Eatontown, New Jersey, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06967259